Design, synthesis, and anticancer activity of novel isocryptolepine ‘aza’ type acyl thiourea derivatives via combined experimental and computational approach
Bioscience Reports · 2026
DOI: 10.1042/bsr20253519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, 2026. Verfasst von Ammara Fayyaz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, 63100, Pakistan. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Thiourea, Antineoplastic Agents, Drug Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To identify novel tyrosinase inhibitors, a series of isocryptolepine ‘aza’ type acyl thiourea analogs (6a–6h) were designed and synthesized using a multistep strategy. Spectroscopic methods including FTIR, UV–vis, 1H NMR, 13C NMR, and EI-MS were utilized for detailed analysis of compounds. Their tyrosinase inhibitory activities were evaluated in vitro, demonstrating superior potency compared with kojic acid (IC50 = 16.83 ± 1.162 μM). The synthesized compounds exhibited IC50 values ranging from 0.832 ± 0.03 to 7.945 ± 0.63 μM, with compound 6g emerging as the most potent inhibitor (IC50 = 0.832 ± 0.03 μM). Kinetic studies revealed competitive inhibition by compound 6g, highlighting its potential as a lead candidate for treating tyrosinase-mediated hyperpigmentation. Additional evaluations showed that these compounds also effectively inhibited other enzymes involved in cancer progression, indicating their broad therapeutic potential. Molecular modeling studies against the tyrosinase enzyme (PDB: 4OUA) confirmed strong binding interactions, while structure-activity relationship analyses provided insights into their inhibitory mechanisms. Geometry optimization of the compounds, supporting their favorable molecular properties. Drug-likeness evaluations further validated the potential of these analogs as promising anti-tyrosinase agents. Overall, this study establishes compound 6g and its analogs as compelling candidates for further development in hyperpigmentation and cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, 63100, Pakistan.
- Sulaiman Bin Abdullah Aba Al-Khail-Centre for Interdisciplinary Research in Basic Sciences (SA-CIRBS), International Islamic University, Islamabad, 44000, Pakistan.
- Department of Basic Science and Humanities, Faculty of Basic and Allied Sciences, Dawood University of Engineering and Technology, Karachi, 74800, Pakistan.
- Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
- Department of MRC Liaquat, University of Medical & Health Sciences Jamshoro, Pakistan.
- Department of Chemistry, Quaid-I-Azam University, Islamabad, 45320, Pakistan.
ORCID-Profile: Syeda Abida Ejaz, Pervaiz Ali Channar, Aamer Saeed
Zitieren
APA
Fayyaz, A., Ejaz, S. A., Ahmed, A., Channar, P. A., Afzal, S., Ujan, R., Saeed, A., Bibi, R., Alsfouk, B. A., Abbas, Q., Sahito, R., Bolte, M., & Hökelek, T. (2026). Design, synthesis, and anticancer activity of novel isocryptolepine ‘aza’ type acyl thiourea derivatives via combined experimental and computational approach. Bioscience Reports. https://doi.org/10.1042/bsr20253519
Vancouver
Fayyaz A, Ejaz SA, Ahmed A, Channar PA, Afzal S, Ujan R, et al. Design, synthesis, and anticancer activity of novel isocryptolepine ‘aza’ type acyl thiourea derivatives via combined experimental and computational approach. Bioscience Reports. 2026. doi:10.1042/bsr20253519
BibTeX
@article{Fayyaz2026,
author = {Fayyaz, Ammara and Ejaz, Syeda Abida and Ahmed, Atteeque and Channar, Pervaiz Ali and Afzal, Saira and Ujan, Rabail and Saeed, Aamer and Bibi, Rifhat and Alsfouk, Bshra A and Abbas, Qamar and Sahito, Reshma and Bolte, Michael and Hökelek, Tuncer},
title = {Design, synthesis, and anticancer activity of novel isocryptolepine ‘aza’ type acyl thiourea derivatives via combined experimental and computational approach},
journal = {Bioscience Reports},
year = {2026},
doi = {10.1042/bsr20253519}
}
EUVIMED